Table 2.

Investigator-assessed response

	N = 101
Best response, n (%, 95% CI)
Objective response	84 (83, 74-90)
CR	59 (58, 48-68)
PR	25 (25, 17-34)
SD	10 (10, 5-17)
PD	5 (5, 2-11)
Not done	2 (2, 0-7)
Ongoing response, n (%)	31 (31)
CR	30 (30)
PR	1 (1)
DOR (95% CI)
Median DOR, mos	11.1 (4.2-51.3)
Median duration of CR, mos	62.2 (12.9-NE)
Median duration of PR, mos	1.9 (1.3-2.1)

PD, progressive disease; PR, partial response; SD, stable disease.